Skip to main content
OpenTrials

Clinical trial condition

Peripheral Nervous System Diseases

Explore clinical trials studying Peripheral Nervous System Diseases. Study availability and eligibility vary by location and protocol.

3,127 public trials 570 recruiting studies
Refine in advanced search Browse all conditions

Peripheral Nervous System Diseases trial results

Active, Not Recruiting

Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

NCT06433219

Conditions
Adnexal Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California San Francisco - UCSF Medical Center San Francisco, California, United States
  • Centricity Research Cancer Center - DBA CRRI John B. Amos Cancer Center Research Columbus, Georgia, United States
  • University of Chicago Comprehensive Cancer Center at Silver Cross - Carolyn J. Czerkies Pavilion Chicago, Illinois, United States
View all 84 locations
View Trial Details
Active, Not Recruiting

NF-1, Nutraceutical Intervention

NCT05363267

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Active, Not Recruiting

Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

NCT05882734

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • UCLA Hematology and Oncology - Santa Monica Santa Monica, California, United States
  • UPMC Cancer Center Pittsburgh, Pennsylvania, United States
  • Tennessee Cancer Specialists - Biomedical Research Knoxville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 54 locations
View Trial Details
Active, Not Recruiting

Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas

NCT05101148

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • Research Site Rochester, Minnesota, United States
  • Research Site Akron, Ohio, United States
  • Research Site Bydgoszcz, Poland
  • Research Site Gdansk, Poland
View Trial Details

Related conditions